TSHA

Taysha Gene Therapies, Inc. is a pioneering gene therapy company located in Dallas, Texas, focused on the development and commercialization of adeno-associated virus-based therapeutics for monogenic diseases impacting the central nervous system. The company boasts a strong pipeline of innovative treatments and utilizes a proprietary gene delivery platform to target significant unmet medical needs in neurology. As Taysha progresses through key clinical development milestones and forges strategic collaborations within the biopharmaceutical sector, it is well-positioned to make a transformative impact in the treatment landscape.